Cargando…
Germline Pathogenic Variants in 7636 Japanese Patients With Prostate Cancer and 12 366 Controls
BACKGROUND: Genetic testing has been conducted in patients with prostate cancer (PCa) using multigene panels, but no centralized guidelines for genetic testing exist. To overcome this limitation, we investigated the demographic and clinical characteristics of patients with pathogenic variants. METHO...
Autores principales: | Momozawa, Yukihide, Iwasaki, Yusuke, Hirata, Makoto, Liu, Xiaoxi, Kamatani, Yoichiro, Takahashi, Atsushi, Sugano, Kokichi, Yoshida, Teruhiko, Murakami, Yoshinori, Matsuda, Koichi, Nakagawa, Hidewaki, Spurdle, Amanda B, Kubo, Michiaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156928/ https://www.ncbi.nlm.nih.gov/pubmed/31214711 http://dx.doi.org/10.1093/jnci/djz124 |
Ejemplares similares
-
Genetic characterization of pancreatic cancer patients and prediction of carrier status of germline pathogenic variants in cancer-predisposing genes
por: Mizukami, Keijiro, et al.
Publicado: (2020) -
Association between germline pathogenic variants in cancer‐predisposing genes and lymphoma risk
por: Usui, Yoshiaki, et al.
Publicado: (2022) -
Germline pathogenic variants of 11 breast cancer genes in 7,051 Japanese patients and 11,241 controls
por: Momozawa, Yukihide, et al.
Publicado: (2018) -
Expansion of Cancer Risk Profile for BRCA1 and BRCA2 Pathogenic Variants
por: Momozawa, Yukihide, et al.
Publicado: (2022) -
Comprehensive evaluation of structural variation detection algorithms for whole genome sequencing
por: Kosugi, Shunichi, et al.
Publicado: (2019)